| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 10/23/2013 | CN103356685A Application of Houttuynoid D in medicine for treating atherosclerosis |
| 10/23/2013 | CN103356684A Application of Houttuynoid E in vascular dilation medicine |
| 10/23/2013 | CN103356683A Application of Houttuynoid C in medicine for treating or preventing acute heart failure |
| 10/23/2013 | CN103356681A Application of Houttuynoid A in preparation of medicines for treating myocardial ischemia |
| 10/23/2013 | CN103356677A Application of Houttuynoid D in medicine for treating or preventing acute heart failure |
| 10/23/2013 | CN103356676A Application of Houttuynoid E in medicine for treating myocardial ischemia |
| 10/23/2013 | CN103356675A Application of Houttuynoid B in preparation of medicine for treating or preventing acute heart failure |
| 10/23/2013 | CN103356673A Application of Houttuynoid A in preparation of medicines for treating or preventing chronic heart failure |
| 10/23/2013 | CN103356672A Application of Houttuynoid A in preparation of vasodilating medicines |
| 10/23/2013 | CN103356671A Application of Houttuynoid C in treating or preventing chronic heart failure |
| 10/23/2013 | CN103356670A Application of Houttuynoid D in medicine for treating or preventing chronic heart failure |
| 10/23/2013 | CN103356669A Application of Houttuynoid A in preparation of medicines for treating or preventing acute heart failure |
| 10/23/2013 | CN103356668A Application of Houttuynoid C in vascular dilation medicine |
| 10/23/2013 | CN103356667A Application of Houttuynoid A in preparation of medicines for treating atherosclerosis |
| 10/23/2013 | CN103356666A Application of Houttuynoid A in preparation of medicines for treating ischemic brain injury |
| 10/23/2013 | CN103356657A Application of Chukrasone A in preparing vasodilating medicines |
| 10/23/2013 | CN103356647A Application of Chukrasone A in preparation medicines for treating myocardial ischemia |
| 10/23/2013 | CN103356644A Application of Chukrasone A in preparation of medicines for treating ischemic brain injury |
| 10/23/2013 | CN103356639A Novel capsule filled with valsartan solid preparation and hydrochlorothiazide solid preparation |
| 10/23/2013 | CN103356638A Tablet capsule filled with irbesartan tablet and thiazole hydrochloride tablet |
| 10/23/2013 | CN103356637A Application of chaetocin in preparation of medicine used for preventing and treating heart diseases |
| 10/23/2013 | CN103356632A Use of Aspeverin in preparation of drugs for treating atherosclerosis |
| 10/23/2013 | CN103356614A Method for treating or preventing thrombosis using dabigatran etexilate or a salt thereof with improved safety profile over conventional warfarin therapy |
| 10/23/2013 | CN103356613A Novel capsule filled with valsartan solid preparation and amlodipine solid preparation |
| 10/23/2013 | CN103356604A Application of Chukrasone B in preparing medicines for treating atherosclerosis |
| 10/23/2013 | CN103356595A Application of Chukrasone B in preparation medicines for treating myocardial ischemia |
| 10/23/2013 | CN103356587A Application of Sarcaboside B in preparation of medicines for treating atherosclerosis |
| 10/23/2013 | CN103356570A Application of Sarcaboside B in medicine used for treating or preventing chronic heart failure |
| 10/23/2013 | CN103356567A Application of Sarcaboside B in preparation of vascular dilation medicines |
| 10/23/2013 | CN103356551A Application of Sarcaboside B in medicine used for treating ischemic brain injury |
| 10/23/2013 | CN103356548A Application of Sarcaboside A in preparation of drug for treating or preventing chronic heart failure |
| 10/23/2013 | CN103356546A Application of Sarcaboside B in medicine used for treating myocardial ischemia |
| 10/23/2013 | CN103356529A Application of Sarcaboside B in preparation of medicines for treating or preventing acute heart failure |
| 10/23/2013 | CN103356526A Application of Sarcaboside A in preparation of drug for treating ischemic brain injury |
| 10/23/2013 | CN103356514A Diarylalkanes as potent inhibitors of binuclear enzymes |
| 10/23/2013 | CN103356513A Applications of delta-elemene and derivative thereof in anti-atherosclerosis |
| 10/23/2013 | CN103356512A Benzenesulfonic acid amlodipine membranaceous preparation |
| 10/23/2013 | CN103356503A Novel amlodipine and benazepril capsule |
| 10/23/2013 | CN103356497A Benzenesulfonate amlodipine tablet and preparation method thereof |
| 10/23/2013 | CN103356493A Preparation method of amlodipine besylate tablets |
| 10/23/2013 | CN103356476A Method for dissolving flavonoid compounds, carbon glycoside compounds or stilbene compounds and preparation method of injection or injectable powder injection |
| 10/23/2013 | CN103355992A Health-care hemorrhoid cushion |
| 10/23/2013 | CN103355842A Hypertension control insole |
| 10/23/2013 | CN103355666A Preparation method of plant enzyme beverage capable of improving cardiovascular and cerebrovascular metabolic functions |
| 10/23/2013 | CN103071003B Traditional Chinese medicine for promoting blood circulation, removing blood stasis and clearing and activating channels and collaterals |
| 10/23/2013 | CN102872048B Application of gypensapogenin B to ischemic brain injury treatment drugs |
| 10/23/2013 | CN102772382B Ophiopogonin dropping pill and preparation method thereof |
| 10/23/2013 | CN102702092B Eutectic of two curcumin organic medicaments and preparation method thereof |
| 10/23/2013 | CN102698093B Chinese medicinal composition for treating liver and kidney deficiency type hypertension and preparation method thereof |
| 10/23/2013 | CN102671001B Traditional Chinese medicine combination for treating hypertension |
| 10/23/2013 | CN102641506B Bivalirudin-polyethylene glycol compound |
| 10/23/2013 | CN102614470B External Chinese herbal composition for treating sequela of apoplexy |
| 10/23/2013 | CN102600072B Tirofiban hydrochloride injecta and preparation method thereof |
| 10/23/2013 | CN102552548B Medicinal liquid for preventing and treating skin disease |
| 10/23/2013 | CN102548988B Azilsartan organic amine salts, preparation method and use thereof |
| 10/23/2013 | CN102512394B Nifedipine sustained release tablets and preparation process thereof |
| 10/23/2013 | CN102512377B Tasteless quick-releasing berberine hydrochloride pellet |
| 10/23/2013 | CN102503935B Azelnidipine crystal form, preparation method for same and officinal composition thereof |
| 10/23/2013 | CN102499967B Ultrasonic-assisted method for preparing garlic blood-pressure-lowering functional factors |
| 10/23/2013 | CN102477038B New lactim compound possessing cardiotonic action, its preparation method and its purpose |
| 10/23/2013 | CN102451465B Use of SIRT1 in preparation of drugs for prevention of diseases caused by endothelial dysfunction |
| 10/23/2013 | CN102258738B Chinese medicinal prescription for treating craniocerebral injury |
| 10/23/2013 | CN102247326B Oral chronopharmacologic drug delivery mini-pill preparation of propranolol and its salts |
| 10/23/2013 | CN102100777B Medicinal liquor for treating stroke sequela |
| 10/23/2013 | CN101757058B General flavone extract of hollyhock flower, preparation thereof and application |
| 10/23/2013 | CN101679298B Fused bicyclic heteroaryl derivatives |
| 10/23/2013 | CN101677943B Multi-dose concentrate esmolol with benzyl alcohol |
| 10/23/2013 | CN101657443B [1,2,3] triazolyl substituted quinolines and coumarins as inhibitors of leukotriene biosynthesis |
| 10/22/2013 | US8563538 Preventing and/or treating cardiovascular disease and/or associated heart failure |
| 10/22/2013 | US8563534 Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis |
| 10/22/2013 | US8563507 Method of treating a disease or condition characterized by aberrant epithelial cell proliferation |
| 10/22/2013 | US8563042 Pharmaceutical composition containing fenofibrate and method for the preparation thereof |
| 10/22/2013 | US8562977 Human aminoacyl-tRNA synthetase polypeptides useful for the regulation of angiogenesis |
| 10/22/2013 | CA2620296C Combination drug containing probucol and a tetrazolylalkoxy-dihydrocarbostyril derivative with superoxide supressant effects |
| 10/22/2013 | CA2572872C Tissue factor production inhibitor |
| 10/22/2013 | CA2528179C Piperidinyl prostaglandin e analogs |
| 10/22/2013 | CA2412626C Il-17 molecules and uses thereof |
| 10/17/2013 | WO2013155512A2 Treatment of ischemic retinopathies |
| 10/17/2013 | WO2013154794A1 Trans 10 : ci s 12 isomer of conjugated linoleic acid as a therapeutic and preventative agent for pregnancy induced hypertension or preeclampsia |
| 10/17/2013 | WO2013154410A1 Use of phenobarbital (phb) in small doses in the treatment of autonomic dysregulations such as sympathetic hyperactivity |
| 10/17/2013 | WO2013154409A1 Use of venlafaxine in the treatment of autonomic dysregulations with sympathetic deficit |
| 10/17/2013 | WO2013154408A1 Use of maprotiline in the treatment of autonomic dysregulation with sympathetic deficiency |
| 10/17/2013 | WO2013154192A1 Medicinal composition for treating infarction |
| 10/17/2013 | WO2013154128A1 Novel arteriosclerosis treatment drug composition and method for screening arteriosclerosis treatment drugs |
| 10/17/2013 | WO2013152717A1 Fused pyrimidine compound, and preparation method, intermediate, composition， and uses thereof |
| 10/17/2013 | WO2013152704A1 5-amino-1,4-dihydro-1,8-naphthyridine derivative and pharmaceutical composition and use thereof |
| 10/17/2013 | WO2013152641A1 Lercanidipine hydrochloride and losartan potassium compound preparation and preparation method thereof |
| 10/17/2013 | WO2013152441A1 Composition for prevention of vasoactivity in the treatment of blood loss and anemia |
| 10/17/2013 | WO2013124748A4 Novel polymorphs of azilsartan medoxomil potassium |
| 10/17/2013 | US20130274252 Quinazoline derivatives as kinase inhibitors |
| 10/17/2013 | US20130273562 1L1RL-1 as a Cardiovascular Disease Marker and Therapeutic Target |
| 10/17/2013 | US20130273042 Treatment of multiple sclerosis |
| 10/17/2013 | US20130273004 Substituted alkylamine derivatives and methods of use |
| 10/17/2013 | US20130272998 Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulations of angiogenesis and anticancer therapy |
| 10/16/2013 | EP2650285A1 Fungicide |
| 10/16/2013 | EP2650279A2 Prodrugs of methyl hydrogen fumarate, pharmaceutical compositions thereof, and methods of use |
| 10/16/2013 | EP2650008A1 Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of various cardiovascular diseases |
| 10/16/2013 | EP2650007A1 Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of various cardiovascular diseases |
| 10/16/2013 | EP2649996A1 Crystalline forms of sartans like telmisartan with beta blockers |
| 10/16/2013 | EP2649062A1 Bicyclic compounds as inhibitors of acetyl-coa carboxylase (acc) |